{"id":"W4408003542","doi":"10.1080/1750743x.2025.2464528","title":"ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Amgen","keywords":"Atopic dermatitis; Medicine; Dermatology; Rocket (weapon); Engineering; Aeronautics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002998478,0.00134752,0.001119552,0.0004637261,0.000418426,0.001118778,0.00103466,0.001116548,0.008013604],"category_scores_gemma":[0.001071141,0.0003428434,0.001430761,0.0003416582,0.0006235951,0.0009161784,0.0004491555,0.003118177,0.001583562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009210706,"about_ca_system_score_gemma":0.002116284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009515012,"about_ca_topic_score_gemma":0.003095512,"domain_scores_codex":[0.999487,0.0002440682,0.00002284903,0.00006640566,0.00007137931,0.0001082066],"domain_scores_gemma":[0.9994681,0.00008497094,0.0001165146,0.00004583278,0.00007929193,0.0002052131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.423326,0.08509511,0.0115173,0.003476603,0.003232424,0.0006206543,0.0004695124,0.006148054,0.09167109,0.001886929,0.06849275,0.3040635],"study_design_scores_gemma":[0.5949134,0.3309817,0.0204991,0.0003414799,0.001286323,0.001077046,0.0001666335,0.003838485,0.01367377,0.0008647682,0.03228221,0.00007519569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9357175,0.01116674,0.003138912,0.003111587,0.0007094993,0.01971198,0.0103799,0.0009359327,0.01512792],"genre_scores_gemma":[0.9258702,0.007577103,0.008996492,0.005267182,0.0004057168,0.01879282,0.0171171,0.0002348991,0.01573839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008013604,"threshold_uncertainty_score":0.0268082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02051525263557304,"score_gpt":0.3718269398653076,"score_spread":0.3513116872297346,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}